Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1612-9067
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07) ; volume:18 ; number:4 ; day:16 ; month:5 ; year:2021 ; pages:835-843 ; date:10.2021
Esophagus ; 18, Heft 4 (16.5.2021), 835-843, 10.2021
- Creator
-
Satoh, Taroh
Kato, Ken
Ura, Takashi
Hamamoto, Yasuo
Kojima, Takashi
Tsushima, Takahiro
Hironaka, Shuichi
Hara, Hiroki
Iwasa, Satoru
Muro, Kei
Yasui, Hirofumi
Minashi, Keiko
Yamaguchi, Kensei
Ohtsu, Atsushi
Doki, Yuichiro
Matsumura, Yasuhiro
Kitagawa, Yuko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10388-021-00850-0
- URN
-
urn:nbn:de:101:1-2021111117462896404242
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Satoh, Taroh
- Kato, Ken
- Ura, Takashi
- Hamamoto, Yasuo
- Kojima, Takashi
- Tsushima, Takahiro
- Hironaka, Shuichi
- Hara, Hiroki
- Iwasa, Satoru
- Muro, Kei
- Yasui, Hirofumi
- Minashi, Keiko
- Yamaguchi, Kensei
- Ohtsu, Atsushi
- Doki, Yuichiro
- Matsumura, Yasuhiro
- Kitagawa, Yuko
- SpringerLink (Online service)
Other Objects (12)
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Correction to: Current management strategies for visceral artery aneurysms: an overview
Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
Predictive factors of late cholangitis in patients undergoing pancreaticoduodenectomy
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Correction to: Current management strategies for visceral artery aneurysms: an overview
Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
Predictive factors of late cholangitis in patients undergoing pancreaticoduodenectomy
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Correction to: Current management strategies for visceral artery aneurysms: an overview
Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
Predictive factors of late cholangitis in patients undergoing pancreaticoduodenectomy